\-\ Texto\\:\\ \ \(0\)\
\-\ absent\\ knee\\ jerk\\ reflex\\.\ \(0\)\
\-\ leg\\ strength\\ only\\ 2\\/5\\.\ \(0\)\
\-\ steroids\\.\ \(34\)\
\-\ follow\\ up\\ mri\\ three\\ months\\ later\\ demonstrated\\ the\\ lesion\\'s\\ stability\\.\ \(0\)\
\-\ mixed\\ signal\\ intensity\\ expansile\\ lesion\\ t9\\ and\\ t10\\.\ \(0\)\
\-\ low\\ signal\\ intensity\\ rim\\ with\\ high\\ signal\\ intensity\\ central\\ nidus\\.\ \(0\)\
\-\ minimal\\ enhancement\\ following\\ contrast\\ administration\\.\ \(0\)\
\-\ cavernous\\ malformation\\,\\ \\ thoracic\\ spinal\\ cord\ \(0\)\
\-\ \\â\\€\\¢\\ astrocytoma\ \(1\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ \\â\\€\\¢\\ hemangioblastoma\ \(1\)\
\-\ \\â\\€\\¢\\ vascular\\ malformation\ \(1\)\
\-\ 53\\ year\\ old\\ female\\ with\\ sudden\\ onset\\ of\\ bilateral\\ leg\\ weakness\\ and\\ numbness\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ intensity\\:\\ 0\\.32977482656630897\ \(0\)\
\-\ signal\\:\\ 0\\.26327120549356525\ \(0\)\
\-\ malformation\\:\\ 0\\.23879767111280387\ \(0\)\
\-\ leg\\:\\ 0\\.23373423091376114\ \(0\)\
\-\ jerk\\:\\ 0\\.2227069857153351\ \(0\)\
\-\ t9\\:\\ 0\\.1894952217644788\ \(0\)\
\-\ t10\\:\\ 0\\.1824980560292175\ \(0\)\
\-\ nidus\\:\\ 0\\.17694018690102448\ \(0\)\
\-\ stability\\:\\ 0\\.15618971411677635\ \(0\)\
\-\ hemangioblastoma\\:\\ 0\\.1548210826152627\ \(0\)\
\-\ reflex\\:\\ 0\\.15309740669886612\ \(0\)\
\-\ lesion\\:\\ 0\\.14843817601058118\ \(0\)\
\-\ 53\\:\\ 0\\.14487572770147097\ \(0\)\
\-\ expansile\\:\\ 0\\.14008238161560313\ \(0\)\
\-\ numbness\\:\\ 0\\.137613519154495\ \(0\)\
\-\ steroids\\:\\ 0\\.13600991845138943\ \(0\)\
\-\ cavernous\\:\\ 0\\.13428624253499288\ \(0\)\
\-\ sudden\\:\\ 0\\.1338719020706955\ \(0\)\
\-\ ependymoma\\:\\ 0\\.130766945492336\ \(0\)\
\-\ strength\\:\\ 0\\.1296884417241343\ \(0\)\
\-\ mixed\\:\\ 0\\.12814702458005264\ \(0\)\
\-\ absent\\:\\ 0\\.12700588703096988\ \(0\)\
\-\ rim\\:\\ 0\\.12328241690421735\ \(0\)\
\-\ administration\\:\\ 0\\.12328241690421735\ \(0\)\
\-\ minimal\\:\\ 0\\.11810346383821066\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.11686711545688057\ \(0\)\
\-\ thoracic\\:\\ 0\\.11568464522910812\ \(0\)\
\-\ cord\\:\\ 0\\.11475408183893088\ \(0\)\
\-\ weakness\\:\\ 0\\.11298353410906513\ \(0\)\
\-\ knee\\:\\ 0\\.11096553381122126\ \(0\)\
\-\ later\\:\\ 0\\.1107893073916534\ \(0\)\
\-\ spinal\\:\\ 0\\.10992494218876965\ \(0\)\
\-\ three\\:\\ 0\\.10392019272617459\ \(0\)\
\-\ central\\:\\ 0\\.10338009981169316\ \(0\)\
\-\ vascular\\:\\ 0\\.10220281180495511\ \(0\)\
\-\ onset\\:\\ 0\\.09940753879973356\ \(0\)\
\-\ only\\:\\ 0\\.09671615440288149\ \(0\)\
\-\ demonstrated\\:\\ 0\\.09514171488994619\ \(0\)\
\-\ following\\:\\ 0\\.09287094654378843\ \(0\)\
\-\ months\\:\\ 0\\.09011161714718038\ \(0\)\
\-\ enhancement\\:\\ 0\\.08910561711837328\ \(0\)\
\-\ low\\:\\ 0\\.0888304932374917\ \(0\)\
\-\ high\\:\\ 0\\.08798354079892155\ \(0\)\
\-\ follow\\:\\ 0\\.0834557297800717\ \(0\)\
\-\ bilateral\\:\\ 0\\.08320030414630622\ \(0\)\
\-\ mri\\:\\ 0\\.07946542877742216\ \(0\)\
\-\ up\\:\\ 0\\.0765783951267294\ \(0\)\
\-\ contrast\\:\\ 0\\.07521874470220252\ \(0\)\
\-\ female\\:\\ 0\\.07470269370681135\ \(0\)\
\-\ and\\:\\ 0\\.06397894972557537\ \(0\)\
\-\ with\\:\\ 0\\.060627246397445364\ \(0\)\
\-\ year\\:\\ 0\\.047709220593335974\ \(0\)\
\-\ old\\:\\ 0\\.04581736672615558\ \(0\)\
\-\ the\\:\\ 0\\.030890092180889128\ \(0\)\
\-\ of\\:\\ 0\\.030295521631766725\ \(0\)\
